# Intramammary Dosage Forms; Ceftiofur
> **Food and Drug Administration** · Final rule. · Published 2005-04-18 · Effective 2005-04-18 · 70 FR 20048
## Document
- **Document number:** 05-7730
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 70 FR 20048
- **CFR reference:** 21 CFR 526
- **Publication date:** 2005-04-18
- **Effective date:** 2005-04-18
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The NADA provides for the veterinary prescription use of ceftiofur hydrochloride suspension, by intramammary infusion, for the treatment of subclinical mastitis in dairy cattle at the time of dry off.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2005/04/18/05-7730/intramammary-dosage-forms-ceftiofur)
---
*AI Analytics · CC0 1.0*